All In Biotech

Investigational drug · Phase 2

NEO100

Also called: Perillyl alcohol

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma.

Phase 2

Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

4

Any phase or sponsor naming "NEO100"

First trial start

2017

Aug 1, 2017

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "NEO100", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Glioblastoma Multiforme
  • Residual, Progressive or Recurrent Grade II or III Meningioma

Approved drugs for the same conditions: Brain tumors (glioma) · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "NEO100" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 447 on PubMed

Also in development for Glioblastoma Multiforme

  • LAM561Phase 32 trials

    Laminar Pharmaceuticals · Primary Glioblastoma, Glioblastoma Multiforme, High-grade Glioma

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • BPM31510Phase 21 trial

    BPGbio · Glioblastoma, Glioblastoma Multiforme

  • NG101mPhase 21 trial

    NeuGATE Theranostics · Glioblastoma Multiforme

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

  • VAL-083Phase 21 trial

    Kintara Therapeutics, Inc. · Glioma, Glioblastoma, Glioblastoma Multiforme

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.